Additional sector guidance – Biotechnology and pharmaceuticals
Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
Responsible Agricultural Investment (RAI) Tool for Agribusiness
Agribusinesses and agri-food investors are increasingly motivated to ensure that their operations and investments generate positive social and environmental outcomes.…
Biodiversity Loss: An Introduction for Risk Professionals
In recent years, biodiversity loss has become an urgent and systemic environmental risk due to its impact on global food…
2022
Webinario sobre Nature Positive: casos de estudio
El concepto de naturaleza positiva ha ganado recientemente mucha tracción entre las empresas a nivel mundial con un número creciente…